Claims
| Claim | Type | Assessment | Score | Review checks | References |
|---|---|---|---|---|---|
| In the study’s Indian hospital-based analysis, three ROTASIIL doses had estimated adjusted effectiveness of 56% against moderate rotavirus gastroenteritis and 54% against severe rotavirus gastroenteritis among children aged 3–23 months. | QUANTITATIVE | Supported | 0.8808 | 1 of 4 | 80 |